Facebook
Twitter
It’s the latest deal in the Marijuana Buyout Boom!
Canada’s No. 2 publicly traded cannabis company is making a major acquisition. And the deal gives the company the exclusive right to import marijuana into Mexico.
The top players in Canada are rushing to secure their global dominance.
This $0.51 international IPO could be the next stock to get bought out.
Go here to get your pre-IPO shares right now.
Last Friday, Aurora Cannabis (NYSE: ACB) announced an exclusive supply agreement with Farmacias Magistrales.
Farmacias Magistrales is a pharmaceutical manufacturer and distributor with a vast network. The company distributes products to 500 pharmacies and hospitals, plus 80,000 retail stores.
The company is the first and only company to receive a license to import cannabis containing THC. The process for receiving this approval took over four years.
News of the deal sent Aurora Cannabis shares rising 8.9% on Friday.
This morning, Aurora issued a second news release related to Farmacias Magistrales…
Aurora will acquire the entire company for an undisclosed price.
The deal highlights the opportunity for Canadian cannabis companies to expand internationally.
Nationwide approval of cannabis means that Canadian companies can operate without any legal issues. That makes it easy for them to work with banks and raise capital from investors.
Of course, Canada is a pretty small country with a population of just 36 million people (that’s smaller than California).
That’s why Canadian companies are rushing to expand internationally, propelling the marijuana buyout boom.
Deloitte Research estimates that the Canadian market for marijuana is worth up to $8.7 billion per year. And that means these companies need to find markets outside of Canada.
The Canadian market is a tiny sliver of the global market estimated to be over $200 billion.
So, how are Canadian companies expanding?
They’re buying up international cannabis companies at a frenzied pace.
One upcoming cannabis IPO could be the next target of Aurora Cannabis or Canopy Growth (NYSE: CGC).
Right now, the private company is planning its IPO for early 2019.
Before that happens, a small group of investors can buy Pre-IPO shares for just $0.51. Plus, the deal includes “free bonus shares” that could help you multiply your profits.
Click here now for urgent details (it’s FREE).